BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24062859)

  • 1. Characterization of the Stoichiometry of HMGA1/DNA Complexes.
    Watanabe M; Ni S; Lindenberger AL; Cho J; Tinch SL; Kennedy MA
    Open Biochem J; 2013; 7():73-81. PubMed ID: 24062859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation.
    Zou Y; Webb K; Perna AD; Zhang Q; Clarke S; Wang Y
    Biochemistry; 2007 Jul; 46(26):7896-906. PubMed ID: 17550233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group A1 and cancer: potential biomarker and therapeutic target.
    Shah SN; Resar LM
    Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
    Brocher J; Vogel B; Hock R
    BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter.
    Grant MA; Baron RM; Macias AA; Layne MD; Perrella MA; Rigby AC
    Biochem J; 2009 Feb; 418(1):103-12. PubMed ID: 18937643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytes.
    Gasparini G; De Gori M; Paonessa F; Chiefari E; Brunetti A; Galasso O
    Arthritis Res Ther; 2012 Oct; 14(5):R207. PubMed ID: 23036517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair.
    Pellarin I; Arnoldo L; Costantini S; Pegoraro S; Ros G; Penzo C; Triolo G; Demarchi F; Sgarra R; Vindigni A; Manfioletti G
    PLoS One; 2016; 11(10):e0164258. PubMed ID: 27723831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
    Edberg DD; Adkins JN; Springer DL; Reeves R
    J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
    Akhter MZ; Sharma A; Rajeswari MR
    Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
    Baron RM; Lopez-Guzman S; Riascos DF; Macias AA; Layne MD; Cheng G; Harris C; Chung SW; Reeves R; von Andrian UH; Perrella MA
    PLoS One; 2010 May; 5(5):e10656. PubMed ID: 20498830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
    Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
    Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nucleotide excision repair by high mobility group protein HMGA1.
    Adair JE; Kwon Y; Dement GA; Smerdon MJ; Reeves R
    J Biol Chem; 2005 Sep; 280(37):32184-92. PubMed ID: 16033759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.
    Zhang Q; Wang Y
    J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability.
    Hassan F; Ni S; Arnett TC; McKell MC; Kennedy MA
    Mol Ther Oncolytics; 2018 Mar; 8():52-61. PubMed ID: 29511732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The energetics of specific binding of AT-hooks from HMGA1 to target DNA.
    Dragan AI; Liggins JR; Crane-Robinson C; Privalov PL
    J Mol Biol; 2003 Mar; 327(2):393-411. PubMed ID: 12628246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-Mediated Regulation of HMGA1 Function.
    Benecke AG; Eilebrecht S
    Biomolecules; 2015; 5(2):943-57. PubMed ID: 26117853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.
    Akhter MZ; Rajeswari MR
    J Photochem Photobiol B; 2014 Dec; 141():36-46. PubMed ID: 25313540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triplex forming oligonucleotides targeted to hmga1 selectively inhibit its expression and induce apoptosis in human cervical cancer.
    Akhter MZ; Rajeswari MR
    J Biomol Struct Dyn; 2017 Mar; 35(4):689-703. PubMed ID: 26923360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene.
    Aiello A; Pandini G; Sarfstein R; Werner H; Manfioletti G; Vigneri R; Belfiore A
    Eur J Cancer; 2010 Jul; 46(10):1919-26. PubMed ID: 20335021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.